{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:21:46Z","timestamp":1772166106680,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T00:00:00Z","timestamp":1756598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T00:00:00Z","timestamp":1756598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"crossref","award":["NNF19OC0054674"],"award-info":[{"award-number":["NNF19OC0054674"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"crossref","award":["NNF19OC0054674"],"award-info":[{"award-number":["NNF19OC0054674"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02886-3","type":"journal-article","created":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T18:10:17Z","timestamp":1756663817000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Left ventricular ejection fraction reserve and its association with myocardial perfusion, coronary calcification, and strain in type 2 diabetes without overt cardiovascular disease"],"prefix":"10.1186","volume":"24","author":[{"given":"Adam","family":"Chebli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida K. B.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Cathrine","family":"Skriver-M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Hasbak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin B.","family":"Blond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor S.","family":"Wasehuus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats C. H.","family":"Lassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Lindhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Kofoed-Enevoldsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urd L.","family":"Kielgast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie H.","family":"Zobel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lene","family":"Holmvang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tor","family":"Biering-S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasmus S.","family":"Ripa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Kjaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tine W.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,31]]},"reference":[{"key":"2886_CR1","volume-title":"IDF diabetes atlas","author":"International Diabetes Federation","year":"2021","unstructured":"International Diabetes Federation. IDF diabetes atlas. 10th ed. Brussels Belgium: International Diabetes Federation; 2021.","edition":"10"},{"key":"2886_CR2","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S179\u2013S218. https:\/\/doi.org\/10.2337\/dc24-S010","DOI":"10.2337\/dc24-S010"},{"issue":"7","key":"2886_CR3","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/eurheartj\/ehad857","volume":"45","author":"to Correction","year":"2024","unstructured":"Correction to. 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes: developed by the task force on the management of cardiovascular disease in patients with diabetes of the European society of cardiology (ESC). Eur Heart J. 2024;45(7):518\u2013518. https:\/\/doi.org\/10.1093\/eurheartj\/ehad857.","journal-title":"Eur Heart J"},{"issue":"2","key":"2886_CR4","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/imj.14995","volume":"52","author":"PM Thein","year":"2022","unstructured":"Thein PM, Mirzaee S, Cameron JD, Nasis A. Left ventricular contractile reserve as a determinant of adverse clinical outcomes: a systematic review. Intern Med J. 2022;52(2):186\u201397. https:\/\/doi.org\/10.1111\/imj.14995.","journal-title":"Intern Med J"},{"issue":"7","key":"2886_CR5","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.jcmg.2009.04.009","volume":"2","author":"S Dorbala","year":"2009","unstructured":"Dorbala S, Hachamovitch R, Curillova Z, et al. Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. J Am Coll Cardiol Img. 2009;2(7):846\u201354. https:\/\/doi.org\/10.1016\/j.jcmg.2009.04.009.","journal-title":"J Am Coll Cardiol Img"},{"issue":"3","key":"2886_CR6","first-page":"349","volume":"48","author":"S Dorbala","year":"2007","unstructured":"Dorbala S, Vangala D, Sampson U, et al. Value of vasodilator left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: A 82Rb PET\/CT study. J Nucl Med. 2007;48(3):349\u201358.","journal-title":"J Nucl Med"},{"issue":"2","key":"2886_CR7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/ehjci\/jeac217","volume":"24","author":"M Rauf","year":"2023","unstructured":"Rauf M, Hansen KW, Galatius S, et al. Prognostic implications of myocardial perfusion imaging by 82-rubidium positron emission tomography in male and female patients with angina and no perfusion defects. Eur Heart J Cardiovasc Imaging. 2023;24(2):212\u201322. https:\/\/doi.org\/10.1093\/ehjci\/jeac217.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"8","key":"2886_CR8","doi-asserted-by":"publisher","first-page":"e015184","DOI":"10.1161\/CIRCIMAGING.122.015184","volume":"16","author":"S H\u00f8jstrup","year":"2023","unstructured":"H\u00f8jstrup S, Hansen KW, Talleruphuus U, et al. Myocardial flow reserve, an independent prognostic marker of All-Cause mortality assessed by 82Rb PET myocardial perfusion imaging: A Danish multicenter study. Circ Cardiovasc Imaging. 2023;16(8):e015184. https:\/\/doi.org\/10.1161\/CIRCIMAGING.122.015184.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"2886_CR9","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/eurheartj\/ehz389","volume":"41","author":"KK Patel","year":"2020","unstructured":"Patel KK, Spertus JA, Chan PS, et al. Myocardial blood flow reserve assessed by positron emission tomography myocardial perfusion imaging identifies patients with a survival benefit from early revascularization. Eur Heart J. 2020;41(6):759\u201368. https:\/\/doi.org\/10.1093\/eurheartj\/ehz389.","journal-title":"Eur Heart J"},{"issue":"12","key":"2886_CR10","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1007\/s10554-023-02948-1","volume":"39","author":"SM Jensen","year":"2023","unstructured":"Jensen SM, Prescott EIB, Abdulla J. The prognostic value of coronary flow reserve in patients with non-obstructive coronary artery disease and microvascular dysfunction: A systematic review and meta-analysis. Int J Cardiovasc Imaging. 2023;39(12):2545\u201356. https:\/\/doi.org\/10.1007\/s10554-023-02948-1.","journal-title":"Int J Cardiovasc Imaging"},{"issue":"3","key":"2886_CR11","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1148\/radiol.2283021006","volume":"228","author":"LJ Shaw","year":"2003","unstructured":"Shaw LJ, Raggi P, Schisterman E, Berman DS, Callister TQ. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology. 2003;228(3):826\u201333. https:\/\/doi.org\/10.1148\/radiol.2283021006.","journal-title":"Radiology"},{"issue":"9","key":"2886_CR12","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.jacc.2003.09.068","volume":"43","author":"P Raggi","year":"2004","unstructured":"Raggi P, Shaw LJ, Berman DS, Callister TQ. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol. 2004;43(9):1663\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2003.09.068.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2886_CR13","doi-asserted-by":"publisher","first-page":"e012599","DOI":"10.1161\/CIRCIMAGING.121.012599","volume":"15","author":"KK Patel","year":"2022","unstructured":"Patel KK, Peri-Okonny PA, Qarajeh R, et al. Prognostic relationship between coronary artery calcium score, perfusion defects, and myocardial blood flow reserve in patients with suspected coronary artery disease. Circ Cardiovasc Imaging. 2022;15(4):e012599. https:\/\/doi.org\/10.1161\/CIRCIMAGING.121.012599.","journal-title":"Circ Cardiovasc Imaging"},{"key":"2886_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12933-016-0333-5","volume":"15","author":"JH Liu","year":"2016","unstructured":"Liu JH, Chen Y, Yuen M, et al. Incremental prognostic value of global longitudinal strain in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2016;15:22. https:\/\/doi.org\/10.1186\/s12933-016-0333-5.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2886_CR15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12933-025-02717-5","volume":"24","author":"AC Skriver-M\u00f8ller","year":"2025","unstructured":"Skriver-M\u00f8ller AC, Hasbak P, Rasmussen IKB, et al. Sex differences in myocardial flow reserve among individuals with type 2 diabetes: insights from the DiaHeart study. Cardiovasc Diabetol. 2025;24(1):172. https:\/\/doi.org\/10.1186\/s12933-025-02717-5.","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"2886_CR16","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006.","journal-title":"Ann Intern Med"},{"issue":"11","key":"2886_CR17","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00259-007-0478-2","volume":"34","author":"M Lortie","year":"2007","unstructured":"Lortie M, Beanlands RS, Yoshinaga K, Klein R, Dasilva JN, DeKemp RA. Quantification of myocardial blood flow with 82Rb dynamic PET imaging. Eur J Nucl Med Mol Imaging. 2007;34(11):1765\u201374. https:\/\/doi.org\/10.1007\/s00259-007-0478-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"16","key":"2886_CR18","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1093\/eurheartj\/ehab775","volume":"43","author":"MA Kelshiker","year":"2022","unstructured":"Kelshiker MA, Seligman H, Howard JP, et al. Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis. Eur Heart J. 2022;43(16):1582\u201393. https:\/\/doi.org\/10.1093\/eurheartj\/ehab775.","journal-title":"Eur Heart J"},{"issue":"4","key":"2886_CR19","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-t","volume":"15","author":"AS Agatston","year":"1990","unstructured":"Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15(4):827\u201332. https:\/\/doi.org\/10.1016\/0735-1097(90)90282-t.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2886_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jcmg.2022.06.018","volume":"16","author":"I Golub","year":"2023","unstructured":"Golub I, Termeie O, Kristo S, et al. Major global coronary artery calcium guidelines. J Am Coll Cardiol Img. 2023;16(1):98\u2013117. https:\/\/doi.org\/10.1016\/j.jcmg.2022.06.018.","journal-title":"J Am Coll Cardiol Img"},{"issue":"10","key":"2886_CR21","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.echo.2015.06.001","volume":"28","author":"M Cusm\u00e0-Piccione","year":"2015","unstructured":"Cusm\u00e0-Piccione M, Zito C, Oreto L, et al. Longitudinal strain by automated function imaging detects single-vessel coronary artery disease in patients undergoing dipyridamole stress echocardiography. J Am Soc Echocardiogr. 2015;28(10):1214\u201321. https:\/\/doi.org\/10.1016\/j.echo.2015.06.001.","journal-title":"J Am Soc Echocardiogr"},{"issue":"6","key":"2886_CR22","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/01.res.27.6.961","volume":"27","author":"RM Abel","year":"1970","unstructured":"Abel RM, Reis RL. Effects of coronary blood flow and perfusion pressure on left ventricular contractility in dogs. Circ Res. 1970;27(6):961\u201371. https:\/\/doi.org\/10.1161\/01.res.27.6.961.","journal-title":"Circ Res"},{"issue":"6","key":"2886_CR23","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1007\/s12350-013-9784-1","volume":"20","author":"A Van Tosh","year":"2013","unstructured":"Van Tosh A, Votaw JR, Reichek N, Palestro CJ, Nichols KJ. The relationship between ischemia-induced left ventricular dysfunction, coronary flow reserve, and coronary steal on regadenoson stress-gated 82Rb PET myocardial perfusion imaging. J Nucl Cardiol. 2013;20(6):1060\u20138. https:\/\/doi.org\/10.1007\/s12350-013-9784-1.","journal-title":"J Nucl Cardiol"},{"issue":"3","key":"2886_CR24","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s12350-021-02729-0","volume":"29","author":"SM Frey","year":"2022","unstructured":"Frey SM, Honegger U, Clerc OF, et al. Left ventricular ejection fraction, myocardial blood flow and hemodynamic variables in adenosine and regadenoson vasodilator 82-Rubidium PET. J Nucl Cardiol. 2022;29(3):921\u201333. https:\/\/doi.org\/10.1007\/s12350-021-02729-0.","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"2886_CR25","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.diabres.2008.06.020","volume":"82","author":"O Yonaha","year":"2008","unstructured":"Yonaha O, Matsubara T, Naruse K, et al. Effects of reduced coronary flow reserve on left ventricular function in type 2 diabetes. Diabetes Res Clin Pract. 2008;82(1):98\u2013103. https:\/\/doi.org\/10.1016\/j.diabres.2008.06.020.","journal-title":"Diabetes Res Clin Pract"},{"key":"2886_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12933-022-01607-4","volume":"21","author":"L Leccisotti","year":"2022","unstructured":"Leccisotti L, Cinti F, Sorice GP, et al. Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART trial: a preliminary report. Cardiovasc Diabetol. 2022;21:173. https:\/\/doi.org\/10.1186\/s12933-022-01607-4.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"2886_CR27","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.jacc.2006.04.089","volume":"48","author":"L Wang","year":"2006","unstructured":"Wang L, Jerosch-Herold M, Jacobs DR Jr, et al. Coronary artery calcification and myocardial perfusion in asymptomatic adults: the MESA (Multi-Ethnic study of Atherosclerosis). J Am Coll Cardiol. 2006;48(5):1018\u201326. https:\/\/doi.org\/10.1016\/j.jacc.2006.04.089.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2886_CR28","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.2967\/jnumed.113.120063","volume":"54","author":"E Hsiao","year":"2013","unstructured":"Hsiao E, Ali B, Blankstein R, et al. Detection of obstructive coronary artery disease using regadenoson stress and 82Rb PET\/CT myocardial perfusion imaging. J Nucl Med. 2013;54(10):1748\u201354. https:\/\/doi.org\/10.2967\/jnumed.113.120063.","journal-title":"J Nucl Med"},{"issue":"3","key":"2886_CR29","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.hfc.2019.02.003","volume":"15","author":"S Paolillo","year":"2019","unstructured":"Paolillo S, Marsico F, Prastaro M, et al. Diabetic cardiomyopathy: definition, diagnosis, and therapeutic implications. Heart Fail Clin. 2019;15(3):341\u20137. https:\/\/doi.org\/10.1016\/j.hfc.2019.02.003.","journal-title":"Heart Fail Clin"},{"issue":"12","key":"2886_CR30","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.jcmg.2023","volume":"16","author":"J Nyberg","year":"2023","unstructured":"Nyberg J, Jakobsen EO, \u00d8stvik A, et al. Echocardiographic reference ranges of global longitudinal strain for all cardiac chambers using guideline-directed dedicated views. J Am Coll Cardiol Img. 2023;16(12):1516\u201331. https:\/\/doi.org\/10.1016\/j.jcmg.2023.","journal-title":"J Am Coll Cardiol Img"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02886-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02886-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02886-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T18:10:18Z","timestamp":1756663818000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02886-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,31]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2886"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02886-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6870088\/v1","asserted-by":"object"}]},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,31]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. All participants provided written consent, and the protocol was approved by the Danish National Committee on Health Research Ethics (H-19063311).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"PR has received speaking fees and\/or consultancy to Steno Diabetes Center Copenhagen from Eli Lilly, Novo Nordisk, Sanofi Aventis, Vifor, Boehringer Ingelheim, Astellas, Gilead, Bayer, AstraZeneca, Mundipharma, and MSD. PR has received research grants from Novo Nordisk AstraZeneca. AC, PR, TWH and RSR had shares in Novo Nordisk. AK and RSR has received consultancy fees from Novo Nordisk. EHZ is a full-time employee in Novo Nordisk and has shares in Novo Nordisk. IKR is a full-time employee at Novo Nordisk. ML: has received speaker and consultancy fees from AstraZeneca, Bayer, Boeringer Ingelheim, Novo Nordisk, GlaxoSmithKline, and is an investigator in clinical studies sponsored by Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Janssen, MSD and Novo Nordisk. JPG has served as consultant for Novo Nordisk on measurement of bioactive peptides. TBS has received research grants from Pfizer, Sanofi Pasteur, GSK, Novo Nordisk, AstraZeneca, Boston Scientific and GE Healthcare, consulting fees from Novo Nordisk, IQVIA, Parexel, Amgen, CSL Seqirus, GSK and Sanofi Pasteur, and lecture fees from Bayer, Novartis, Sanofi Pasteur, GE healthcare and GSK. The other authors declare that there is no duality of interest associated with this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"352"}}